In conclusion, our findings suggested that tumor‐derived Gal1 promoted the secretion of CCL20 by TAMs, thereby recruiting Tregs as collaborators in tumor development and impeding the function and infiltration of CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.